Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v9-FR Version v1-EN
Language French English
Date Updated 2018-06-20 2018-03-02
Drug Identification Number 02370433 02370433
Brand name SUBLINOX SUBLINOX
Common or Proper name SUBLINOX SUBLINOX
Company Name BAUSCH HEALTH, CANADA INC. BAUSCH HEALTH, CANADA INC.
Ingredients ZOLPIDEM TARTRATE ZOLPIDEM TARTRATE
Strength(s) 10MG 10MG
Dosage form(s) TABLET (ORALLY DISINTEGRATING) TABLET (ORALLY DISINTEGRATING)
Route of administration SUBLINGUAL SUBLINGUAL
Packaging size na na
ATC code N05CF N05CF
ATC description HYPNOTICS AND SEDATIVES HYPNOTICS AND SEDATIVES
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2018-03-15
Actual start date 2018-03-21
Estimated end date Unknown
Actual end date 2018-06-18
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments